Home > PJ (current issue) > Leading article | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7349 p570
14 May 2005

This article
Reprint   Photocopy

PDF 45K, Acrobat Reader

Leading Article

New beginnings

Now that the names of the new Privy Council nominees have been announced, together with the name of the academic pharmacist representative from schools of pharmacy in Great Britain (p571 and p595), the Council of the Royal Pharmaceutical Society is likely to have a different take on matters. Including the pharmacists and the pharmacy technicians elected to Council for the first time (PJ, 16 April, p461), the academic pharmacist and the Privy Council nominees, there will be 18 new faces in the Council chamber.

The 10 Privy Council nominees will bring a wide range of expertise to the Society and to Council meetings. The fact that a number of them have current or recent experience of working within other health organisations should be of great benefit to the profession. The Journal suspects that, in addition to their role as custodians of the public interest, they may have relevant advice to offer about how pharmacy’s role in the care of patients can be enhanced and how pharmacy’s voice can be better heard in health service forums.

Another new beginning can be found at Richmond House — the home of the Department of Health in Whitehall. The Cabinet reshuffle sees the departure of John Reid to defence — perhaps a happier home for a man who has a reputation for being abrasive. At this stage it is not known who will be responsible for pharmacy issues. Rosie Winterton is still in situ, as is Lord Warner. Both of them have had a significant part to play in the fortunes of pharmacy.

However, a shudder went through The Journal when we learnt that the new Secretary of State for Health is to be Patricia Hewitt (p572). Without doubt she is an able politician and an intelligent woman but, having been Secretary of State for Trade and Industry since 2001 and, before that, had junior ministerial posts in the Treasury as well as at the Department of Trade and Industry, we wonder how sympathetic she will be to pharmacy. It was, after all, a report from the Office of Fair Trading (part of the DTI) on control of entry two years ago that so unsettled the community sector.

Experience tells many of us that a first encounter often clouds our view of issues ever after. So, the challenge for Ms Hewitt, and for her new team, will be to pick up a pair of health service spectacles and learn to focus with them as quickly as possible. Developments in pharmacy contractual matters over the next couple of years and how she reacts to what the OFT has next in store for the profession will determine how successful she will have been.

Back to Top


©The Pharmaceutical Journal